AFT PharmaceuticalsNZSE:AFT +0.82%95 Days Inventory is 152.55 as of Mar. 2026, which is 3% below its 10-year median of 157.83. GuruFocus rates NZSE:AFT with a GF Score™ of 95/100 and a GF Value™ of NZ$4.16 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 918 Drug Manufacturers companies, AFT Pharmaceuticals ranks better than 55.12% on this metric.
The historical rank and industry rank for AFT Pharmaceuticals's Days Inventory or its related term are showing as below:
NZSE:AFT'
s Days Inventory Range Over the Past 10 Years
Min: 152.24 Med: 157.83 Max: 203.76
Current: 152.24
During the past 11 years, AFT Pharmaceuticals's highest Days Inventory was 203.76. The lowest was 152.24. And the median was 157.83.
NZSE:AFT's Days Inventory is ranked better than 55.12% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs NZSE:AFT: 152.24
AFT Pharmaceuticals's Days Inventory
increased
from Mar. 2025 (133.63) to Mar. 2026 (152.55).
It might indicate that AFT Pharmaceuticals's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
AFT Pharmaceuticals's Inventory Turnover for the
six
months ended in Mar. 2026 was 1.20.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
AFT Pharmaceuticals's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.48.
AFT Pharmaceuticals (NZSE:AFT) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
AFT Pharmaceuticals's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
AFT Pharmaceuticals's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
AFT Pharmaceuticals Days Inventory Related Terms
AFT Pharmaceuticals Days Inventory Historical Data
* Premium members only.
The historical data trend for AFT Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NZSE:AFT vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, AFT Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AFT Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AFT Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where AFT Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AFT Pharmaceuticals (NZSE:AFT) has a Days Inventory of 152.55 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on AFT Pharmaceuticals and its competitors. This is near median its historical median of 157.83. Over the past decade, AFT Pharmaceuticals' Days Inventory has ranged from 152.24 to 203.76. According to the industry distribution chart, AFT Pharmaceuticals ranks #412 out of 918 companies in the Drug Manufacturers industry, placing it in the top 44.9%.
Is AFT Pharmaceuticals' Days Inventory too high?
AFT Pharmaceuticals' current Days Inventory of 152.55 is near median its 10-year median of 157.83. Over the past 10 years, this metric has ranged from a low of 152.24 to a high of 203.76. The Drug Manufacturers industry median Days Inventory is 164.43. AFT Pharmaceuticals' value of 152.55 is 7.2% below this industry median. Based on the distribution chart, AFT Pharmaceuticals ranks #412 out of 918 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, AFT Pharmaceuticals has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does AFT Pharmaceuticals' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, AFT Pharmaceuticals ranks #412 out of 918 companies for Days Inventory. This puts AFT Pharmaceuticals in the upper half of its industry. The industry median Days Inventory is 164.43. AFT Pharmaceuticals' value of 152.55 is 7.2% below this benchmark. Historically, AFT Pharmaceuticals' own Days Inventory has ranged from 152.24 to 203.76 over the past decade. While the company's 10-year median is 157.83 vs. the industry median of 164.43, AFT Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AFT Pharmaceuticals's current Days Inventory of 152.55 is 7.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on AFT Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AFT Pharmaceuticals's current Days Inventory is 152.55, which is near median its own 10-year median of 157.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AFT Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, AFT Pharmaceuticals (NZSE:AFT) is currently considered Modestly Undervalued. The stock's GF Value™ is NZ$4.16, compared to a current price of NZ$3.70 — trading 11.1% below its estimated fair value. The current Days Inventory is 152.55, which is near median its 10-year median of 157.83 and 7.2% below the Drug Manufacturers industry median of 164.43. AFT Pharmaceuticals' overall GF Score™ is 95/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For AFT Pharmaceuticals (NZSE:AFT), the current Days Inventory is 152.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AFT Pharmaceuticals (NZSE:AFT) Overvalued in 2026?
Based on GuruFocus' analysis, AFT Pharmaceuticals stock appears to be undervalued.
The current stock price of NZ$3.70 is trading 11.1% below its estimated GF Value™ of NZ$4.16.
GuruFocus considers AFT Pharmaceuticals to be Modestly Undervalued.
Key valuation signals for NZSE:AFT:
Days Inventory: 152.55 (near median its 10-year median of 157.83)
GF Value™: NZ$4.16 vs. price of NZ$3.70 (11.1% below fair value)
Industry Position: 7.2% below the Drug Manufacturers median (#412 of 918)
No single metric tells the full story. See the NZSE:AFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Maxigesic dose forms, Capsaicin creams, Crystaderm, Kiwisoothe, Micolette, and others. The group has four operating segments based on geographical location being Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia, which includes the sales and distribution activity relating to the Australian market.
95GF Score
Get the complete analysis for NZSE:AFT
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:AFT has been successfully added to your 
